AZD8848: Clinical Trials

8 trials of AZD8848, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6
Phase 22Completed 2

Follow AZD8848: new trials by email Literature Review of AZD8848 trials Research Report on AZD8848

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects
AZD8848, Placebo to match AZD8848 - Safety,, Tolerability,
Phase 1CompletedAstraZeneca82014-01-012015-08-14
AZD8848 Single Ascending Dose Study
AZD8848, Placebo - Healthy
Phase 1CompletedAstraZeneca472012-05-012016-06-06
A Study to Investigate the Impact of Dose and Dosing Frequency of AZD8848 on the Response on Biomarkers
AZD8848, Placebo - Healthy Volunteers
Phase 1CompletedAstraZeneca552010-11-012015-08-14
Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848
AZD8848, Placebo, AZD8848 and placebo - Allergic Rhinitis
Phase 2CompletedAstraZeneca932010-09-012016-01-07
Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects
AZD8848 - Butyrylcholinesterase Deficiency
Phase 1CompletedAstraZeneca222010-09-012015-08-14
The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen
AZD8848, Placebo - Allergic Asthma
Phase 2CompletedAstraZeneca602009-10-012016-02-26
Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848
AZD8848, Placebo - Allergic Rhinitis
Phase 1CompletedAstraZeneca1032008-09-012015-08-14
Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season
AZD8848, Placebo - Healthy, Allergic Rhinitis
Phase 1CompletedAstraZeneca1302008-01-012015-08-14

Conditions studied

Rhinitis, Allergic (3)  ·  Respiratory Aspiration (2)  ·  Butyrylcholinesterase deficiency (1)

Sponsors

AstraZeneca (8)

Countries

Sweden (4)  ·  United Kingdom (3)  ·  Denmark (1)

Top investigators

Leif T Eriksson, MD, PhD (2)  ·  Sam Lindgren, MD, PhD (2)  ·  Ajay Aggarwal (1)  ·  Aray Aggarwal (1)  ·  Brian Leaker, MD (1)  ·  James Ritter, BA,MA D Phil,BM BCh,MRCP,FRCP (1)  ·  Jesper Sonne, MD (1)  ·  Leif Eriksson, MD (1)  ·  Leif T Eriksson (1)  ·  Lennart Greiff, MD PhD (1)  ·  Lennart Greiff, MD, PhD (1)  ·  Tim Mant, BSc, MB BS, MRCP, FRCP, FFPM (1)  ·  Wolfgang Kuhn, MD (1)

Results publications

PMID 22726593, PMID 26342289, PMID 26933507, PMID 31856838